Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Thomas A. Mace, Reena Shakya, Omar Elnaggar, Kristin Wilson, Hannah M. Komar, Jennifer Yang, Jason R. Pitarresi, Gregory S. Young, Michael C. Ostrowski, Thomas Ludwig, Tanios Bekaii-Saab, Mark Bloomston, Gregory B. Lesinski
Published Oct 31, 2015 · Vol. 6, No. 42 · pp. 44509-44522
Brandon G. Smaglo, Anteneh Tesfaye, Thorvardur R. Halfdanarson, Joshua E. Meyer, Jue Wang, Zoran Gatalica, Sandeep Reddy, David Arguello, Patrick M. Boland
Published Oct 20, 2015 · Vol. 6, No. 41 · pp. 43594-43604
Marco Scarpa, Cesare Ruffolo, Fabio Canal, Melania Scarpa, Silvia Basato, Francesca Erroi, Alain Fiorot, Lucia Dall’Agnese, Anna Pozza, Andrea Porzionato, Ignazio Castagliuolo, Angelo P. Dei Tos, Nicolò Bassi, Carlo Castoro
Published Oct 19, 2015 · Vol. 6, No. 41 · pp. 43472-43482